Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Frequently asked questions
What sector does Indivior PLC Ordinary Shares (INDV) operate in?
Indivior PLC Ordinary Shares belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Indivior PLC Ordinary Shares (INDV) current stock price?
As of the latest data, Indivior PLC Ordinary Shares stock price is $34.56, with a previous close of $34.47. Indivior PLC Ordinary Shares gained $0.09 in the last trading session, representing a 0.26% increase.
What is Indivior PLC Ordinary Shares (INDV) current market capitalization?
Indivior PLC Ordinary Shares market cap is approximately 4.08 billion.
What is Indivior PLC Ordinary Shares (INDV) Earnings Per Share (EPS)?
The trailing EPS is $2.79, and the forward EPS is $4.88.
What is Indivior PLC Ordinary Shares (INDV) Price-to-Earnings (P/E) ratio?
Indivior PLC Ordinary Shares current P/E ratio is 12.39, with a forward P/E of 7.08.
What is Indivior PLC Ordinary Shares (INDV) EBITDA?
Indivior PLC Ordinary Shares EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 162.00 million.
Does Indivior PLC Ordinary Shares (INDV) pay dividends?
No. Indivior PLC Ordinary Shares does not pay a dividend.
How did Indivior PLC Ordinary Shares (INDV) perform in its most recent earnings report?
In the last report (June 30, 2026), Indivior PLC Ordinary Shares posted an EPS surprise of 18.56% and a revenue surprise of 11.53%.
When is Indivior PLC Ordinary Shares (INDV) next earnings report?
Indivior PLC Ordinary Shares is expected to release its next earnings report on September 30, 2026.
What is Indivior PLC Ordinary Shares (INDV) beta (volatility) score?
Indivior PLC Ordinary Shares has a beta of 1.177, meaning its volatility is roughly in line with the market.
